For millions of Americans, the small orange prescription bottle sitting on the kitchen table represents much more than medicine. It can represent a monthly calculation: which prescriptions need refilling, how much the pharmacy will charge, what insurance will cover and whether there will still be enough left for groceries, utilities and everything else. Now, Medicare beneficiaries are approaching another change that deserves attention before the next enrollment season begins, because a temporary federal program that has helped restrain premiums for stand-alone Medicare Part D prescription drug plans will end on December 31, 2026. (cms.gov, abcnews.com)
The Centers for Medicare & Medicaid Services announced in late July that it would discontinue the Part D Premium Stabilization Demonstration for 2027, returning stand-alone prescription drug plans to what CMS describes as more traditional market conditions. The program was introduced in 2025 during a major redesign of Medicare’s prescription drug benefit and was intended to prevent beneficiaries from suddenly facing dramatic premium increases while insurers adjusted to the new system. (beckerspayer.com)
Its disappearance does not mean every Medicare beneficiary will suddenly receive an enormous bill in January, nor does it mean the underlying Part D prescription benefit is disappearing. What it does mean is that one of the mechanisms that has been cushioning premiums for stand-alone drug plans will no longer exist, making it especially important for beneficiaries to look carefully at their individual 2027 plan rather than automatically renewing the coverage they have today.
The program was created because premiums were at risk of soaring
To understand why this matters, it helps to go back to 2024, when Medicare was preparing for some of the largest changes to Part D since the prescription drug benefit was created.
The Inflation Reduction Act significantly redesigned Medicare Part D, including changes intended to reduce how much beneficiaries can be required to spend out of pocket on covered prescription drugs. Those reforms brought important protections for patients, but they also shifted more financial responsibility toward the private insurance companies offering Part D plans.
Government analysts became concerned that insurers could respond by substantially increasing premiums.
The Government Accountability Office later found that the normal limits on annual premium increases would not have been sufficient to prevent significant increases in 2025 and that premiums for some Part D plans could potentially have nearly doubled without additional intervention. (gao.gov)
CMS therefore introduced the temporary Premium Stabilization Demonstration.
During 2025, participating stand-alone prescription drug plans received additional federal assistance designed to lower beneficiary premiums by as much as $15 per month while also limiting how sharply participating plans could increase premiums from one year to the next. The protections were reduced for 2026, when the additional premium reduction fell to $10 per member per month and plans were allowed greater flexibility in their annual increases. (aol.com, gao.gov)
Altogether, CMS officials estimated that the demonstration would cost approximately $9.8 billion across 2025 and 2026. (gao.gov)
For beneficiaries, however, the complicated mechanics happening behind the scenes were largely invisible.
They simply saw the premium attached to their prescription drug plan.
That is why the end of the program could catch some people by surprise.
What changes on January 1, 2027?
Beginning in 2027, the additional protections provided through the demonstration will disappear for stand-alone Part D plans.
CMS says insurers now have enough experience with the redesigned prescription drug benefit to accurately price their plans without the temporary demonstration, and the agency has therefore decided not to continue it. (cms.gov, beckerspayer.com)
The change primarily matters to people enrolled in stand-alone Medicare Part D prescription drug plans, commonly called PDPs.
These are plans purchased separately by beneficiaries who generally receive their medical coverage through Original Medicare and need separate insurance for prescription medications.
It is an enormous group.
About 25 million Americans were enrolled in stand-alone Part D plans in 2026, representing roughly 44% of all people with Medicare prescription drug coverage. (aol.com)
Those beneficiaries will want to pay particularly close attention to the notices arriving from their insurers this fall.
Does this mean everyone’s premium will increase?
No — and this is where some of the more alarming headlines can become misleading.
The end of the demonstration removes a subsidy and premium-stabilization mechanism, but it does not automatically establish what every individual Part D plan will charge in 2027.
Premiums vary considerably by insurer, plan and location.
Some beneficiaries could pay more.
Others could see relatively modest changes.
And some plans could potentially become cheaper.
CMS Administrator Mehmet Oz has said that premiums are expected to rise by less than $10 per month for most Medicare recipients, while some beneficiaries may even see lower premiums. Final individual plan prices, however, will determine what any particular person actually pays. (aol.com)
That is an important distinction.
A retiree should not look at this announcement and assume, “My premium is definitely going up by $50.”
But neither should someone assume that because their current plan worked well in 2026, it will automatically remain the best option in 2027.
The safest conclusion right now is much simpler:
Check your plan when the 2027 numbers arrive.
One important 2027 number is already known
CMS has already released some of the technical figures used for next year’s Part D program.
For 2027, the national average monthly bid amount has been set at $296.05, while the national base beneficiary premium will be $41.33. (cms.gov, beckerspayer.com)
The second figure deserves an explanation because it is easy to misunderstand.
A national base beneficiary premium of $41.33 does not mean everyone enrolled in Part D will pay exactly $41.33 per month.
Actual premiums can be higher or lower depending on the plan, and people with higher incomes may also pay an additional income-related Medicare adjustment.
The figure is part of the formula Medicare uses to determine Part D premiums and subsidies, rather than a universal price tag applied to every beneficiary.
What retirees ultimately need to see is the price of their own plan.
Your cheapest plan this year may not be your cheapest plan next year
This is perhaps the most practical lesson from the announcement.
Medicare prescription plans can change every year.
A plan can change its premium.
It can alter deductibles and copayments.
It can modify the list of covered medications, known as its formulary.
It can move a medication into a different pricing tier.
It can change which pharmacies receive preferred pricing.
And a competing insurer can introduce a plan that suddenly becomes considerably cheaper for someone taking the same medications.
That means simply looking at the monthly premium is not enough.
Imagine that one plan costs $5 less each month but places an expensive medication on a higher tier. The beneficiary could save $60 annually in premiums while spending hundreds of dollars more at the pharmacy.
For another person taking mostly inexpensive generic medicines, the lower-premium plan might genuinely be the better choice.
The answer depends on the individual.
The letter arriving this fall could be extremely important
Every autumn, Medicare plans send beneficiaries an Annual Notice of Change, often abbreviated as ANOC.
It is one of those documents that can easily end up unopened on a kitchen counter because it looks like another piece of insurance paperwork.
This year, it deserves a closer look.
The notice explains how the beneficiary’s current plan will change for the following year, including changes involving premiums, cost-sharing and coverage.
If the monthly premium is increasing significantly, that is a reason to compare alternatives.
If an important medication is changing tiers or disappearing from the formulary, that can be even more important.
And if the plan’s preferred pharmacy network changes, someone could discover that the pharmacy they have used for years is no longer the least expensive place to fill prescriptions.
A few minutes reviewing that document could potentially make a meaningful difference to a household’s annual medical expenses.
October 15 is the date beneficiaries should remember
Medicare’s annual Open Enrollment Period begins October 15 and continues through December 7.
During that period, people with Medicare can review and change their Medicare health and prescription drug coverage for the following year. (cms.gov)
For 2027, that comparison may be particularly worthwhile for people with stand-alone Part D plans.
Instead of asking only, “How much is my premium?”, beneficiaries should compare the total expected annual cost of each available plan using the prescriptions they actually take.
That means checking the premium, deductible, medication prices and pharmacy network together.
Someone taking six prescriptions every month has very different needs from someone taking one inexpensive generic medication, even if both people are 72 and live in the same town.
Another major Medicare protection remains
There is also some genuinely positive news that should not get lost in discussion about premiums.
The major redesign of Medicare Part D created stronger protections against extremely high prescription drug expenses, including an annual limit on out-of-pocket spending for covered Part D drugs.
The decision to end the temporary premium demonstration does not erase the underlying Part D benefit redesign.
In other words, the story is not simply that “Medicare is taking away prescription drug coverage.”
It isn’t.
The change concerns a temporary program that provided additional support to help stabilize premiums while insurers transitioned to the redesigned Part D system. (factcheck.org, gao.gov)
That distinction matters enormously, particularly for older beneficiaries who may encounter frightening social-media posts suggesting their Medicare drug benefits are disappearing entirely.
They are not.
Why some senior advocates are still worried
Even if most beneficiaries experience relatively modest changes, senior advocates argue that the end of the program could still create difficulties for certain households.
People living primarily on Social Security often budget extremely carefully, and an additional $10, $20 or $30 each month can matter when combined with higher food prices, housing expenses, utilities and other medical costs.
The Medicare Rights Center has warned that ending the demonstration could put upward pressure on stand-alone Part D premiums, particularly because the program had specifically been designed to keep those premiums under control during the transition. (medicarerights.org)
AARP has similarly highlighted concerns that the early end of the program could result in higher monthly premiums for some older adults. (aarp.org)
The concern isn’t necessarily that every beneficiary will experience a dramatic increase.
It is that the effects will vary, meaning some people could face a much more noticeable change than others.
Don’t compare plans using premium alone
When enrollment opens, one mistake can be particularly costly: sorting plans according to their monthly premium and choosing whichever appears cheapest.
Instead, look at the medications you actually take.
A plan with a $20 premium but expensive copayments could cost considerably more over twelve months than a $35 plan providing better coverage for your particular prescriptions.
The same applies to pharmacies.
Part D plans often negotiate different prices with different pharmacy networks, meaning the same medication under the same insurance plan can sometimes cost more depending on where the prescription is filled.
For someone taking several medications every day, those differences can accumulate quickly.
The goal should therefore be to find the lowest total expected cost, not simply the lowest premium.
Beware of scammers when Medicare enrollment approaches
There is another reason this year’s changes deserve attention.
Whenever Medicare rules change, scammers gain a new story to use.
Someone may call claiming that beneficiaries must “update” their Medicare account because of the new Part D rules, perhaps asking for a Medicare number, Social Security number, banking information or payment.
An unexpected caller does not need any of those details simply because the premium stabilization demonstration is ending.
Beneficiaries who want to review Medicare coverage can use official Medicare resources or seek assistance from legitimate counseling services rather than responding to unsolicited calls demanding personal information.
Changes to Medicare can be complicated enough without criminals deliberately adding confusion.
What beneficiaries should do now
There is no need to panic or immediately change anything in August.
The most useful action right now is simply to know that a change is coming.
When 2027 plan information becomes available, find your current premium and compare it with the new one.
Then check every medication you regularly take.
Look at the deductible.
Check the copayments.
Confirm that your preferred pharmacy remains in the plan’s network.
And compare at least a few alternatives before allowing your existing coverage to renew automatically.
CMS maintains the official Medicare resources beneficiaries can use during enrollment, and the annual enrollment window provides time to make a different choice if another plan better suits their needs.
The bottom line for 2027
The Medicare Part D story for 2027 is not that every retiree is about to receive an enormous prescription drug bill.
The real story is more important — and more useful.
A temporary federal program that has helped restrain premiums for stand-alone Part D plans during the transition to Medicare’s redesigned prescription drug benefit ends December 31, 2026. Approximately 25 million Americans currently use stand-alone Part D plans, so millions of households could see some type of change when 2027 pricing arrives. (aol.com)
CMS believes most premium changes will remain relatively modest, but nobody should assume that means their particular plan will remain the cheapest or best option.
For retirees who have spent years carefully stretching every Social Security check, the smartest response is not fear.
It is attention.
When that Medicare notice arrives this fall, don’t automatically throw it into the paperwork pile. Open it, compare the numbers and check your medications, because a plan that made perfect sense in 2026 may look very different when January 2027 arrives.
To learn more about other financial changes heading your way, check out how Social Security Checks Could Rise Again in 2027 – But the Number Retirees Actually Keep May Be Smaller Than It Looks, or read about The FBI Is Warning Older Americans About a Scam That Can End With a Stranger at Your Door. We also have exciting news about how the FDA Approves First-of-Its-Kind Pancreatic Cancer Drug After Patients in Major Trial Lived Nearly Twice as Long.
